{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:23:33Z","timestamp":1773213813219,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"BioNexus KC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypertension is a recognized comorbidity for COVID-19. The association of antihypertensive medications with outcomes in patients with hypertension is not fully described. However, angiotensin-converting enzyme 2 (ACE2), responsible for host entry of the novel coronavirus (SARS-CoV-2) leading to COVID-19, is postulated to be upregulated in patients taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). Here, we evaluated the occurrence of pulmonary adverse drug events (ADEs) in patients with hypertension receiving ACEIs\/ARBs to determine if disparities exist between individual drugs within the respective classes using data from the FDA Spontaneous Reporting Systems. For this purpose, we proposed the proportional reporting ratio to provide a statistical summary for the commonality of an ADE for a specific drug as compared to the entire database for drugs in the same or other classes. In addition, a statistical procedure, multiple logistic regression analysis, was employed to correct hidden confounders when causative covariates are underreported or untrusted to correct analyses of drug-ADE combinations. To date, analyses have been focused on drug classes rather than individual drugs which may have different ADE profiles depending on the underlying diseases present. A retrospective analysis of thirteen pulmonary ADEs showed significant differences associated with quinapril and trandolapril, compared to other ACEIs and ARBs. Specifically, quinapril and trandolapril were found to have a statistically significantly higher incidence of pulmonary ADEs compared with other ACEIs as well as ARBs (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) for group comparison (i.e., ACEIs vs. ARBs vs. quinapril vs. trandolapril) and (<jats:italic>P<\/jats:italic>\u2009\u2264\u20090.0007) for pairwise comparison (i.e., ACEIs vs. quinapril, ACEIs vs. trandolapril, ARBs vs. quinapril, or ARBs vs. trandolapril). This study suggests that specific members of the ACEI antihypertensive class (quinapril and trandolapril) have a significantly higher cluster of pulmonary ADEs.<\/jats:p>","DOI":"10.1038\/s41598-021-92734-7","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T10:03:07Z","timestamp":1624615387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity"],"prefix":"10.1038","volume":"11","author":[{"given":"Majid","family":"Jaberi-Douraki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Riviere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuwan Indika Millagaha","family":"Gedara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald J.","family":"Wyckoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"92734_CR1","unstructured":"Hilal-Danden, R. Renin and Angiotensin. in Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics (eds. Brunton, L. L., Hilal-Dandon, R. & Knollman, B. C.) (McGraw-Hill https:\/\/accessmedicine-mhmedical-com.proxy.library.umkc.edu\/content.aspx?bookid=2189&sectionid=170106980#1162537642)."},{"key":"92734_CR2","unstructured":"CDC. Facts About Hypertension. Centers for Disease Control and Prevention (2020)."},{"key":"92734_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James, P. A. et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA J. Am. Med. Assoc. 311, 507\u2013520 (2014).","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"92734_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000065","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K. et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults a report of the American College of Cardiology\/American Heart Association Task Force on Clinical pr. Hypertension https:\/\/doi.org\/10.1161\/HYP.0000000000000065 (2018).","journal-title":"Hypertension"},{"key":"92734_CR5","unstructured":"Allan S. Brett, M. ACE Inhibitors and ARBs During the COVID-19 Pandemic. NEJM J. Watch 2020, (2020)."},{"key":"92734_CR6","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang, L., Karakiulakis, G. & Roth, M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. Lancet Respir. Med. 8, e21 (2020).","journal-title":"Lancet Respir. Med."},{"key":"92734_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923","author":"G Mancia","year":"2020","unstructured":"Mancia, G., Rea, F., Ludergnani, M., Apolone, G. & Corrao, G. Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of Covid-19. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2006923 (2020).","journal-title":"N. Engl. J. Med."},{"key":"92734_CR8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"92734_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14751","author":"RSG Sablerolles","year":"2021","unstructured":"Sablerolles, R. S. G. et al. No association between use of ACE inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) study. Br. J. Clin. Pharmacol. https:\/\/doi.org\/10.1111\/bcp.14751 (2021).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"92734_CR10","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1016\/j.japh.2020.05.018","volume":"60","author":"EG Stafford","year":"2020","unstructured":"Stafford, E. G. et al. Pharmacovigilance in patients with diabetes: a data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality. J. Am. Pharm. Assoc. 60, e145\u2013e152 (2020).","journal-title":"J. Am. Pharm. Assoc."},{"key":"92734_CR11","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.15272","author":"G Lippi","year":"2020","unstructured":"Lippi, G., Wong, J. & Henry, B. M. Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. Polish Arch. Intern. Med. https:\/\/doi.org\/10.20452\/pamw.15272 (2020).","journal-title":"Polish Arch. Intern. Med."},{"key":"92734_CR12","unstructured":"WHO. Coronavirus disease (COVID-19) Situation Report-108. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200507covid-19-sitrep-108.pdf?sfvrsn=44cc8ed8_2."},{"key":"92734_CR13","unstructured":"Madrigal, A. & Meyer, R. The COVID Tracking Project. The COVID Tracking Project https:\/\/covidtracking.com\/ (2020)."},{"key":"92734_CR14","unstructured":"European Centre for Disease Prevention and Control. COVID-19. Situation update worldwide, as of 6 April 2020. https:\/\/www.ecdc.europa.eu\/en\/geographical-distribution-2019-ncov-cases (2020)."},{"key":"92734_CR15","unstructured":"Almukhtar, S. et al. Coronavirus in the U.S.: Latest Map and Case Count - The New York Times. The New York Times https:\/\/www.nytimes.com\/interactive\/2020\/us\/coronavirus-us-cases.html (2020)."},{"key":"92734_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet. Infect. Dis 20, 533\u2013534 (2020).","journal-title":"Lancet. Infect. Dis"},{"key":"92734_CR17","unstructured":"C3.ai COVID-19 Data Lake - C3.ai. https:\/\/c3.ai\/products\/c3-ai-covid-19-data-lake\/."},{"key":"92734_CR18","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry Good Pharmacovigilance Assessment Guidance for Industry Practices and Pharmacoepidemiologic Assessment. Serv. U.S. Dep. Heal. Hum. Adm. Food Drug (CDER), Cent. Drug Eval. Res. Cent. Biol. Eval. Res. 1\u201320 (2005)."},{"key":"92734_CR19","unstructured":"Fryar, C. D., Ostchega, Y., Hales, C. M., Zhang, G. & Kruszon-Moran, D. Hypertension Prevalence and Control Among Adults: United States ,2015\u20132016. Centers for Disease Control National Center for Health Statistics (2017)."},{"key":"92734_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.09.20126813","author":"W Allen","year":"2020","unstructured":"Allen, W. et al. Population-scale longitudinal mapping of COVID-19 symptoms, behavior, and testing identifies contributors to continued disease spread in the United States. medRxiv. Prepr. Serv. Heal. Sci. https:\/\/doi.org\/10.1101\/2020.06.09.20126813 (2020).","journal-title":"medRxiv. Prepr. Serv. Heal. Sci."},{"key":"92734_CR21","doi-asserted-by":"crossref","unstructured":"Ryan, C. et al. Predicting severe outcomes in Covid-19 related illness using only patient demographics, comorbidities and symptoms. Am. J. Emerg. Med. (2020).","DOI":"10.1016\/j.ajem.2020.09.017"},{"key":"92734_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003377","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti, N. P., Ye, P. P., Daneshjou, R. & Altman, R. B. Data-driven prediction of drug effects and interactions. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.3003377 (2012).","journal-title":"Sci. Transl. Med."},{"key":"92734_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786","author":"PC Austin","year":"2011","unstructured":"Austin, P. C. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav. Res. https:\/\/doi.org\/10.1080\/00273171.2011.568786 (2011).","journal-title":"Multivariate Behav. Res."},{"key":"92734_CR24","unstructured":"Kreutz, G. & Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4, J. E. Practical Aspects of Signal Detection in Pharmacovigilance: Report of CIOMS Working Group VIII. Council for International Organizations of Medical Sciences 146 https:\/\/cioms.ch\/wp-content\/uploads\/2018\/03\/WG8-Signal-Detection.pdf (2010)."},{"key":"92734_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/HJH.0000000000002706","volume":"39","author":"JB Cohen","year":"2021","unstructured":"Cohen, J. B., D\u2019Agostino McGowan, L., Jensen, E. T., Rigdon, J. & South, A. M. Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor\/angiotensin II receptor blocker use during COVID-19: beyond confounding. J. Hypertension 39, 795\u2013805 (2021).","journal-title":"J. Hypertension"},{"key":"92734_CR26","doi-asserted-by":"crossref","unstructured":"Whiting, P. et al. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann. Internal Med. 140 (2004).","DOI":"10.7326\/0003-4819-140-3-200402030-00010"},{"key":"92734_CR27","doi-asserted-by":"crossref","unstructured":"Elwert, F. & Winship, C. Endogenous selection bias: the problem of conditioning on a collider variable. Ann. Rev. Sociol. 40 (2014).","DOI":"10.1146\/annurev-soc-071913-043455"},{"key":"92734_CR28","doi-asserted-by":"crossref","unstructured":"Whiting, P. F., Rutjes, A. W. S., Westwood, M. E. & Mallett, S. A systematic review classifies sources of bias and variation in diagnostic test accuracy studies. J. Clin. Epidemiol. 66 (2013).","DOI":"10.1016\/j.jclinepi.2013.05.014"},{"key":"92734_CR29","doi-asserted-by":"crossref","unstructured":"Rothman, K. J., Lanes, S. & Sacks, S. T. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol. Drug Saf. 13, (2004).","DOI":"10.1002\/pds.1001"},{"key":"92734_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/pds.848","volume":"12","author":"N Moore","year":"2003","unstructured":"Moore, N. et al. Biases affecting the proportional reporting ratio (PRR) in spontaneous reports pharmacovigilance databases: the example of sertindole. Pharmacoepidemiol. Drug Saf. 12, 271\u2013281 (2003).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"92734_CR31","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511810725.005","author":"WG Cochran","year":"2006","unstructured":"Cochran, W. G. & Rubin, D. B. Controlling bias in observational studies: a review. Matched Sampling for Causal Effects https:\/\/doi.org\/10.1017\/CBO9780511810725.005 (2006).","journal-title":"Matched Sampling for Causal Effects"},{"key":"92734_CR32","doi-asserted-by":"crossref","unstructured":"Mann, C. J. Observational research methods. Research design II: Cohort, cross sectional, and case-control studies. Emergency Med. J. 20 (2003).","DOI":"10.1136\/emj.20.1.54"},{"key":"92734_CR33","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1248\/bpb.26.712","volume":"26","author":"N Hayase","year":"2003","unstructured":"Hayase, N. et al. Protective effects of quinaprilat and trandolaprilat, active metabolites of quinapril and trandolapril, on hemolysis induced by lysophosphatidylcholine in human erythrocytes. Biol. Pharm. Bull. 26, 712\u2013716 (2003).","journal-title":"Biol. Pharm. Bull."},{"key":"92734_CR34","unstructured":"Code of Federal Regulations 21CFR310.305. (Food and Drug Administration)."},{"key":"92734_CR35","unstructured":"Code of Federal Regulations 21CFR314.80. (Food and Drug Administration)."},{"key":"92734_CR36","doi-asserted-by":"crossref","unstructured":"Xu, X. et al. Making Sense of Pharmacovigilance and Drug Adverse Event Reporting: Comparative Similarity Association Analysis Using AI Machine Learning Algorithms in Dogs and Cats. Top. Companion Anim. Med. 37, (2019).","DOI":"10.1016\/j.tcam.2019.100366"},{"key":"92734_CR37","first-page":"168","volume":"03","author":"G Kaur","year":"2014","unstructured":"Kaur, G. Usage of regular expressions in NLP. Int. J. Res. Eng. Technol. 03, 168\u2013174 (2014).","journal-title":"Int. J. Res. Eng. Technol."},{"key":"92734_CR38","doi-asserted-by":"publisher","unstructured":"Zhang, S., He, L., Vucetic, S. & Dragut, E. C. Regular expression guided entity mention mining from noisy web data. in Proceedings of the 2018 Conference on Empirical Methods in Natural Language Processing, EMNLP 2018 1991\u20132000 (Association for Computational Linguistics, 2020). https:\/\/doi.org\/10.18653\/v1\/d18-1224.","DOI":"10.18653\/v1\/d18-1224"},{"key":"92734_CR39","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1136\/amiajnl-2013-002411","volume":"21","author":"DDA Bui","year":"2014","unstructured":"Bui, D. D. A. & Zeng-Treitler, Q. Learning regular expressions for clinical text classification. J. Am. Med. Inform. Assoc. 21, 850\u2013857 (2014).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"92734_CR40","unstructured":"Sawsaa, A. & Lu, J. Extracting Information Science Concepts Based on JAPE Regular Expression. in Proceedings of the International Conference on Internet Computing (2011)."},{"key":"92734_CR41","doi-asserted-by":"crossref","unstructured":"Sangers, J., Frasincar, F., Hogenboom, F. & Chepegin, V. Semantic Web service discovery using natural language processing techniques. Expert Syst. Appl. 40, (2013).","DOI":"10.1016\/j.eswa.2013.02.011"},{"key":"92734_CR42","unstructured":"Pettersson, E., Megyesi, B. & Nivre, J. Normalisation of historical text using context-sensitive weighted levenshtein distance and compound splitting. 19th Nord. Conf. 1, (2013)."},{"key":"92734_CR43","doi-asserted-by":"crossref","unstructured":"P. Pande, B. & S. Dhami, H. Application of natural language processing tools in stemming. Int. J. Comput. Appl. 27, (2011).","DOI":"10.5120\/3302-4530"},{"key":"92734_CR44","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart, D. S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucl. Acids Res. 34, 668\u2013672 (2006).","journal-title":"Nucl. Acids Res."},{"key":"92734_CR45","unstructured":"CDC. People with certain medical conditions. Centers for Disease Control and Prevention (2021)."},{"key":"92734_CR46","doi-asserted-by":"crossref","unstructured":"Marron, R. M. et al. Impact of chronic obstructive pulmonary disease and emphysema on outcomes of hospitalized patients with COVID-19 Pneumonia. Chronic Obstr. Pulm. Dis. J. COPD Found. 8, (2021).","DOI":"10.15326\/jcopdf.2020.0200"},{"key":"92734_CR47","doi-asserted-by":"crossref","unstructured":"Stevens, D. V., Tran, A. Q. & Kim, E. Complications of orbital emphysema in a COVID-19 patient. Ophthalmology 127 (2020).","DOI":"10.1016\/j.ophtha.2020.05.011"},{"key":"92734_CR48","doi-asserted-by":"crossref","unstructured":"Elmokadem, A. H. et al. Mimickers of novel coronavirus disease 2019 (COVID-19) on chest CT: spectrum of CT and clinical features. Insights into Imaging 12 (2021).","DOI":"10.1186\/s13244-020-00956-6"},{"key":"92734_CR49","unstructured":"B\u00f6hm, R. Primer on disproportionality analysis. Openvigil (2015)."},{"key":"92734_CR50","unstructured":"DataCamp. prcomp function | R Documentation. https:\/\/www.rdocumentation.org\/packages\/stats\/versions\/3.6.2\/topics\/prcomp (2020)."},{"key":"92734_CR51","unstructured":"Package \u2018factoextra\u2019 Type Package Title Extract and Visualize the Results of Multivariate Data Analyses. https:\/\/github.com\/kassambara\/factoextra\/issues (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92734-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92734-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92734-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T10:53:15Z","timestamp":1670064795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92734-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92734"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92734-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13349"}}